Interleukin-6-deficient mice develop mature-onset obesity

Area of Science:

• Endocrinology
• Metabolism
• Neuroscience

Background:

• Interleukin-6 (IL-6) is an immune-modulating cytokine found in adipose tissue and the brain.
• Hypothalamic nuclei expressing IL-6 are crucial for regulating body composition.
• Dysregulation of IL-6 signaling is implicated in metabolic disorders.

Purpose of the Study:

• To investigate the role of IL-6 in regulating body composition and metabolism.
• To determine the mechanism and site of action for IL-6's anti-obesity effects.

Main Methods:

• Utilized gene-deficient mice (Il6-/-) to study the impact of IL-6 loss on body composition.
• Administered IL-6 centrally (intracerebroventricular) and peripherally (intraperitoneal) in rats to assess its effects on energy expenditure.
• Analyzed metabolic parameters including carbohydrate and lipid metabolism, and leptin levels.

Main Results:

• Il6-/- mice developed mature-onset obesity, characterized by disturbed carbohydrate and lipid metabolism.
• Obese Il6-/- mice exhibited increased leptin levels and reduced leptin responsiveness.
• Central, but not peripheral, IL-6 administration increased energy expenditure in rats.

Conclusions:

• Central IL-6 signaling plays a critical role in preventing obesity and regulating energy expenditure.
• IL-6 acts centrally within the hypothalamus to exert anti-obesity effects.
• Targeting central IL-6 pathways may offer therapeutic strategies for obesity and metabolic dysfunction.